Neuropsychological findings in Parkinson's disease: a comparison between various tests during long-term levodopa therapy
Botez, M.I.; Barbeau, A.
International Journal of Neurology 10(1-4): 222-232
1975
ISSN/ISBN: 0020-7446 PMID: 1181311 Document Number: 83493
Document emailed within 1 workday
Related Documents
Molina, J.A.; Jiménez-Jiménez, F.J.; Ortí-Pareja, M. 1999: Motor and mental complications in the long-term treatment of complicated Parkinson's disease with levodopa Revista de Neurologia 28(10): 982-9901997: Parkinson disease--planning of long-term therapy Der Nervenarzt 68(12 Suppl Morbus Par): 1-8
Goulley, F.; Wolmark, Y.; Bourdeix, I.; Chaumet-Riffaud, P.D. 1993: Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms Therapie 48(3): 233-238
Stern, P.H.; McDowell, F.; Miller, J.M.; Robinson, M. 1970: Levodopa and physical therapy in treatment of patients with Parkinson's disease Archives of Physical Medicine and Rehabilitation 51(5): 273-277
Lee, S.T.; Lu, C.S. 1996: Ventrolateral thalamotomy for dyskinesia following levodopa therapy of Parkinson's disease Journal of the Formosan Medical Association 95(12): 943-945
Singer, E. 1976: Sociopsychological factors influencing response to levodopa therapy for Parkinson's disease Archives of Physical Medicine and Rehabilitation 57(1): 328-334
Klivényi, Péter.; Vécsei, László. 2007: Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease Ideggyogyaszati Szemle 60(1-2): 61-64
Bermejo, F.; Martínez, P.; de Yébenes, J.G. 1986: Parkinson disease, adverse effects of chronic levodopa therapy and drug holidays Archivos de Neurobiologia 49(5): 300-302
Muenter, M.D. 1970: Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease Neurology 20(12 Suppl): 6-13
Szczudlik, A.; Rudzińska, M. 2007: Are dopamine agonists alternative therapy for levodopa in early stage of Parkinson's disease? Yes Neurologia i Neurochirurgia Polska 41(2 Suppl 1: S6-S9
Fuchs, G. 1997: Parkinson disease--problems in long-term treatment. Dopamine agonists optimize L-dopa therapy Fortschritte der Medizin 115(5): 43-45
Block, A.J. 1986: Neuropsychological aspects of long-term oxygen therapy European Journal of Respiratory Diseases. Suppl 146: 417-419
Lieberman, A.N.; Gopinathan, G.; Neophytides, A.; Pasternack, P. 1986: Use of carbidopa as an adjuvant to levodopa/carbidopa therapy in patients with Parkinson's disease New York State Journal of Medicine 86(12): 655-656
Ludin, H.P. 1984: Long-term therapy of the Parkinson syndrome Schweizerische Medizinische Wochenschrift 114(33): 1131-1136
Daniel Llach, M.; Pérez Campdepadrós, M.; Baza Ceballos, N.; Igual Brull, L.; Badell Serra, I.; Puig Reichach, T.; Cubells Rieró, J. 2001: Long and medium-term neuropsychological sequelae of bone marrow transplantation in pediatric patients with hematological disease Anales Espanoles de Pediatria 54(5): 463-467
Mengden, H.J.; Just, H.; Giesecke, J. 1978: Short-term and long-term therapy with slow-release ISDN. Echographic, vector cardiographic and ergometric findings Münchener Medizinische Wochenschrift 120(34): 1085-1090
Vajda, F.J.; Donnan, G.A.; Bladin, P.F. 1978: Patterns of response to levodopa in Parkinson's disease Clinical and Experimental Neurology 15: 299-306
Białecka, M.; Adamiak, U.; Gawrońska-Szklarz, B. 2009: Optimisation of treatment of Parkinson's disease with levodopa Neurologia i Neurochirurgia Polska 43(5): 446-459
Larsen, J.P.; Nessler, E.G.; Hestnes, A.; Vilming, S.; Holmsen, R.; Aksnes, V.; Johnson, S.; Brodtkorb, E.; Hunstad, N.A.; Helle, J.R. 1991: Treatment of Parkinson disease with levodopa depot preparations Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(26): 3163-3166
Clough, C.G.; Bergmann, K.J.; Yahr, M.D. 1984: Cholinergic and dopaminergic mechanisms in Parkinson's disease after long-term L-DOPA administration Advances in Neurology 40: 131-140